Navigation Links
EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
Date:7/25/2012

ROCKVILLE, Md., July 25, 2012 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company, announced today the initiation of a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer. Jennifer R. Diamond, MD at the University of Colorado serves as the principal investigator for the study. The study is sponsored by EntreMed and is supported by a grant from the National Cancer Institute.  More information about the clinical trial can be found at www.ClinicalTrials.gov.

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO)

Jennifer R. Diamond, MD, stated, "Triple-negative breast cancer represents an aggressive breast cancer subtype which carries a high risk of developing distant metastasis.  It remains an area of unmet need in terms of effective anti-cancer agents with innovative patient selection strategies. We are encouraged by the data from the Phase 1 study of ENMD-2076 in patients with advanced solid tumors, including triple-negative breast cancer. ENMD-2076 has also demonstrated significant anti-tumor activity against preclinical models of breast cancer with more robust activity against triple-negative breast cancer alone or in combination with standard chemotherapies.  This single-agent Phase 2 study is designed to determine the activity of ENMD-2076 by the clinical benefit rate in patients with previously treated locally advanced or metastatic triple-negative breast cancer."

Ken Ren, Ph.D., EntreMed's Chief Executive Officer commented, "The development of ENMD-2076 to address the unmet medical need for an effective treatment of triple-negative breast cancer represents a part of our integrated initiatives in the clinical advancement of the ENMD-2076 oncology platform.
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Reports First Quarter 2012 Financial Results
2. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
3. Psyadon Announces Positive Interim Analysis of Phase 2 Study of Ecopipam for the Treatment of Tourette Syndrome
4. Egalet Announces Issuance of U.S. Patent
5. Nektar Announces Start of Enrollment in Phase 2 Study of NKTR-181, a Novel Opioid Analgesic Molecule, for Treatment of Chronic Pain
6. Sancilio and Company Announces New Directors
7. Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer
8. K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing Criteria
9. Kraton Performance Polymers, Inc. Announces Second Quarter 2012 Earnings Release Conference Call and Webcast and 2012 Investor Day and Webcast
10. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
11. Hologic Announces Pricing Of Financing In Connection With Acquisition Of Gen-Probe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... , Oct. 2, 2014  MJ Freeway®, the ... two important webinars detailing upcoming legalization efforts in ... and Nevada .  The success of ... of marijuana legalization on the national level. ... and Co-Founder of the Marijuana Policy Project, an organization ...
(Date:10/2/2014)...  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... conference call to provide an update on the ... Rx in infants and children with spinal ... the morning (CEST) of Friday, October 10 at ... GermanyWhen:Friday, October 10 at 11:30 a.m. ET / ...
(Date:10/1/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide and ... markets in the United States , ... agreement with Patterson Veterinary Supply. Patterson ... of Abaxis veterinary products throughout the United ...
Breaking Medicine Technology:MJ Freeway to Host Educational Webinars Regarding Crucial Marijuana Legalization Efforts in Alaska, Nevada and Oregon 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 2Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 3Abaxis Announces Distribution Agreement with Patterson Veterinary Supply 4
... PAUL, Minn., Feb. 22, 2011 New research shows people ... to be at an increased risk of developing Parkinson,s disease, ... at the American Academy of Neurology ,s 63rd Annual ... Benzedrine and dexedrine are amphetamines often prescribed to increase ...
... Grifols, a global healthcare company and biopharmaceutical manufacturer ... long-term cooperative agreement with the diagnostics business of ... products in the US.  Under the terms of ... immunohematology instruments, assays and other products following US ...
Cached Medicine Technology:Using Amphetamines May Increase Risk of Parkinson's Disease 2Grifols Signs Cooperative Agreement for Commercialization of Immunohematology Diagnostic Products in the US 2
(Date:10/2/2014)... When a child, deaf person or elderly ... keep them from wandering off. "In order to eliminate this ... three inventors from Yulee, Fla. , The BUZZ ME helps ... and deters them from wandering off. This avoids stress and ... use and compact, the device can be produced in design ...
(Date:10/2/2014)... 2014 The Business Intelligence Group ... Awards for Business program. The BIG Awards specialize ... proprietary judging process scored by well-known and experienced ... “The winners this year epitomize what is going ... of the Business Intelligence Group. “The sheer amount ...
(Date:10/2/2014)... News) -- Scientists have pinpointed a molecule that may ... The researchers say this finding could offer a ... these attacks. Most asthma attacks (80 percent to ... airways, according to the British researchers. Most of these ... common cold. The researchers found that a specific ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, 2014 (HealthDay News) ... -- may face an increased risk of dying in the next ... 3,000 older Americans, researchers found those who were unable to detect ... times as likely to die in the next five years, versus ... -- the inability to distinguish odors -- was a bigger predictor ...
(Date:10/1/2014)... is strongly associated with Alzheimer,s disease; however, researchers are ... the causal agent of the onset and development of ... that beta-amyloid is not harmful when found in isolation ... self-assembles to form the so-called amyloid fibrils , "We ... but with multiple ones because each aggregate of peptide, ...
Breaking Medicine News(10 mins):Health News:Innovation Dominant Theme among 2014 Big Awards for Business Winners and Finalists 2Health News:New Clues to How Colds Can Spur Asthma Attacks 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2
... NEW YORK, March 19 The Department of ... York is a 2009 winner of the American Pain Society,s ... number of pain centers for excellence and innovation in interdisciplinary ... acknowledges the many challenges encountered in maintaining a team of ...
... its recent analysis of the field of orthopedic tissue ... with the 2009 North American Technology Innovation of the ... scaffold for use in orthopedic and spine tissue engineering. ... that it provides a suitable matrix for cell growth ...
... Dr. Friedberg vs. The American Society of Anesthesiologists, Action ... doctor against 43,000 doesn,t seem like very fair odds. ... cosmetic surgery anesthesia, Dr. Barry Friedberg, set the stage ... Society of Anesthesiologists, (ASA) March 9 press release in ...
... Legislative Language to Health Provisions , ... Newport Beach, ... human resource and benefits management services , today released a ... In the face of the significant changes from Barack Obama’s ...
... transcription services to group practices, multi-specialty clinics and community health ... Neurological Associates. , ... Scottsdale, AZ ... provider of medical transcription services to group ...
... ALCMI,s founding organization, the Bonnie J. Addario Lung Cancer ... advertising campaign to raise $20 from one million people in ... CBS Outdoor and friends of the Foundation to raise awareness ... billboards in New York City, Los Angeles, Washington, D.C., San ...
Cached Medicine News:Health News:The Department of Pain Medicine and Palliative Care at Beth Israel Medical Center is Named 2009 Center of Excellence Award Winner by the American Pain Society 2Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 2Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 3Health News:Frost & Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E-Matrix 4Health News:Dr. Barry Friedberg comments on David vs. Goliath: Who's Really in the Pursuit of Patient Safety & Satisfaction? 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 2Health News:Secova Reports Healthcare Provisions In The Stimulus Bill 3Health News:MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates 2Health News:MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates 3Health News:Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research 2Health News:Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: